| Charlotte Pham, DO | |
|
508 Fulton St, Durham, NC 27705-3875 | |
| (919) 286-0411 | |
| Not Available |
| Full Name | Charlotte Pham |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 508 Fulton St, Durham, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255710745 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 0102206601 (Virginia) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 63665 (Connecticut) | Primary |
| Entity Name | Hartford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407806391 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000700 |
News Archive
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).
"Relief agencies have warned that millions of North Koreans are malnourished, with the most vulnerable facing starvation in the coming months, despite reports that the impoverished state has received food aid from China and South Korea," the Lancet reports.
Silence Therapeutics plc announces the issuance of United States patent 7,723,316, titled Compositions and Methods of RNAi Therapeutics For Treatment of Cancer and Other Neovascularization Disease, by the United States Patent and Trademark Office (USPTO).
› Verified 2 days ago
| Entity Name | Hartford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770696643 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000752 |
News Archive
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).
"Relief agencies have warned that millions of North Koreans are malnourished, with the most vulnerable facing starvation in the coming months, despite reports that the impoverished state has received food aid from China and South Korea," the Lancet reports.
Silence Therapeutics plc announces the issuance of United States patent 7,723,316, titled Compositions and Methods of RNAi Therapeutics For Treatment of Cancer and Other Neovascularization Disease, by the United States Patent and Trademark Office (USPTO).
› Verified 2 days ago
| Entity Name | The Hospital Of Central Connecticut At New Britain General And Bradley |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063461481 PECOS PAC ID: 6507776564 Enrollment ID: O20040115000497 |
News Archive
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).
"Relief agencies have warned that millions of North Koreans are malnourished, with the most vulnerable facing starvation in the coming months, despite reports that the impoverished state has received food aid from China and South Korea," the Lancet reports.
Silence Therapeutics plc announces the issuance of United States patent 7,723,316, titled Compositions and Methods of RNAi Therapeutics For Treatment of Cancer and Other Neovascularization Disease, by the United States Patent and Trademark Office (USPTO).
› Verified 2 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).
"Relief agencies have warned that millions of North Koreans are malnourished, with the most vulnerable facing starvation in the coming months, despite reports that the impoverished state has received food aid from China and South Korea," the Lancet reports.
Silence Therapeutics plc announces the issuance of United States patent 7,723,316, titled Compositions and Methods of RNAi Therapeutics For Treatment of Cancer and Other Neovascularization Disease, by the United States Patent and Trademark Office (USPTO).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charlotte Pham, DO 1501 White Pine Drive, Durham, NY 24405-2896 Ph: (917) 853-5977 | Charlotte Pham, DO 508 Fulton St, Durham, NC 27705-3875 Ph: (919) 286-0411 |
News Archive
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).
"Relief agencies have warned that millions of North Koreans are malnourished, with the most vulnerable facing starvation in the coming months, despite reports that the impoverished state has received food aid from China and South Korea," the Lancet reports.
Silence Therapeutics plc announces the issuance of United States patent 7,723,316, titled Compositions and Methods of RNAi Therapeutics For Treatment of Cancer and Other Neovascularization Disease, by the United States Patent and Trademark Office (USPTO).
› Verified 2 days ago
Elena Hart, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3643 N Roxboro St, Durham, NC 27704 Phone: 919-470-4000 | |
Dr. Carolyn Keeler, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Dumc 3807, Durham, NC 27710 Phone: 919-684-7821 | |
Raphael S. Orenstein, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 120 William Penn Plz, Durham, NC 27704 Phone: 919-220-5255 Fax: 919-220-6971 | |
Mazen Zein, D.O Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Duke Medicine Circle Spine Center Clinic 1b/1c, Durham, NC 27710 Phone: 919-660-3006 | |
Shane Sullivan, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 4221 Garrett Rd, Durham, NC 27707 Phone: 919-937-9607 | |
Dr. Paul Edwind Howell Jr., M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 508 Fulton St # 117, Durham, NC 27705 Phone: 919-286-0411 Fax: 919-416-5913 | |
Eugenia Fay Zimmerman, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 120 William Penn Plz, Durham, NC 27704 Phone: 919-220-5255 Fax: 919-220-6971 |